The groundbreaking treatment of this peptide represents a major development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide078133.onzeblog.com/42202915/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment